10-Q: HeartCore Q2 Sees Profit Surge Amid Nasdaq Woes

HeartCore Enterprises reported a significant turnaround to net income in Q2 2025, driven by strong software sales and cost reductions, despite a decline in overall six-month revenue and ongoing Nasdaq compliance challenges.

Summary

• Q2 2025 net income was $1,061,506, a substantial improvement from a net loss of $2,211,118 in Q2 2024.
• Q2 2025 revenues increased by 16.7% to $4,744,246, primarily due to large on-premise software orders and SaaS expansion in Japan.
• Gross profit surged by 175.2% to $2,217,595 in Q2 2025, with gross profit margin improving to 46.7% from 19.8% in Q2 2024, driven by increased sales and cost reductions in customized software development.
• For the six months ended June 30, 2025, total revenues decreased by 8.6% to $8,331,272, mainly due to slowdowns in customized software development and GO IPO consulting services.
• Net loss for the six months ended June 30, 2025, was reduced to $2,075,875 from $3,689,120 in the prior year period.
• The company is not in compliance with Nasdaq's $1.00 minimum bid price requirement (deadline November 3, 2025) and $2,500,000 minimum stockholders' equity requirement (extension until September 30, 2025).
• Secured new capital through an Equity Purchase Agreement for up to $25 million and a Securities Purchase Agreement for $2 million in Series A Convertible Preferred Stock with Crom Structured Opportunities Fund I, LP.
• Board approved a non-binding letter of intent to sell 100% of HeartCore Japan for approximately $12 million cash.

Sentiment

Score: 4

Explanation: While Q2 showed a significant profit turnaround and gross margin improvement, the overall six-month revenue decline, increased operational cash burn, and critical Nasdaq compliance issues (bid price and stockholders' equity) indicate significant underlying challenges and financial instability. The capital raises are positive for liquidity but highlight the need for external funding to address these issues. The potential sale of HeartCore Japan could be a positive step but also signals a significant restructuring.

Positives

• Significant turnaround to net income of $1,061,506 in Q2 2025, compared to a net loss of $2,211,118 in Q2 2024.
• Gross profit increased by 175.2% to $2,217,595 in Q2 2025, with gross profit margin improving by 26.9 percentage points to 46.7%.
• Strong growth in on-premise software revenue (up $1,155,548 in Q2 2025) and SaaS revenue (up $134,571 in Q2 2025) due to large orders and focused expansion.
• Reduced cost of revenues by 22.5% in Q2 2025, primarily through cost-cutting in customized software development and improved operational efficiency in GO IPO consulting services.
• General and administrative expenses decreased by 22.7% in Q2 2025 due to intangible asset impairment and lower consultant fees.
• Successfully raised $2 million through the issuance of Series A Convertible Preferred Stock and secured a commitment for up to $25 million via an Equity Purchase Agreement, addressing liquidity concerns and Nasdaq compliance.
• Entered into new consulting agreements with tmsuk Co. Ltd. and Cipher Core Co., Ltd., each valued at $500,000 plus warrants, expanding the GO IPO business.
• Board approved a non-binding letter of intent to sell HeartCore Japan for approximately $12 million, which could significantly improve financial position and address Nasdaq compliance.

Negatives

• Overall revenues for the six months ended June 30, 2025, decreased by 8.6% to $8,331,272 compared to the same period in 2024.
• Customized software development and services revenue decreased by $677,091 for the six months ended June 30, 2025, due to intensified competition in the U.S. software market.
• GO IPO consulting services revenue decreased by $302,759 for the six months ended June 30, 2025, due to fewer ongoing projects.
• Net cash flows used in operating activities increased to $2,674,892 for the six months ended June 30, 2025, from $1,735,744 in the prior year, indicating higher cash burn from operations.
• Accumulated deficit stands at $18,231,933 as of June 30, 2025.
• Selling expenses increased by 114.9% in Q2 2025 due to employee restructuring to sales, impacting profitability.
• Disclosure controls and procedures were not effective as of June 30, 2025.

Risks

• Non-compliance with Nasdaq's $1.00 minimum bid price requirement, with a deadline of November 3, 2025, to regain compliance, potentially requiring a reverse stock split.
• Non-compliance with Nasdaq's $2,500,000 minimum stockholders' equity requirement, with an extension until September 30, 2025, to regain compliance. Failure to meet this could lead to delisting.
• Intensified competition in the U.S. software market, impacting customized software development and services revenue.
• Fluctuations in the fair value of investments in marketable securities and warrants can significantly impact other income/expenses.
• Reliance on estimates and assumptions in financial reporting, which could differ from actual results.
• Potential for significant future reversal of variable noncash consideration in consulting services revenue recognition.
• The proposed sale of HeartCore Japan is subject to price adjustment and may not close, impacting the company's financial outlook and Nasdaq compliance efforts.
• The impact of the One Big Beautiful Bill Act (OBBBA) on U.S. corporate income tax is still being evaluated and could affect financial statements.

Future Outlook

The company is actively working to regain compliance with Nasdaq's minimum bid price and stockholders' equity requirements, including considering a reverse stock split and leveraging recent capital raises. Strategic shifts are underway to focus on on-premise software and SaaS revenue growth, while reducing reliance on customized software development and GO IPO consulting services. The potential sale of HeartCore Japan for approximately $12 million is under evaluation and could significantly impact future financial position.

Management Comments

• "We are currently monitoring the closing bid price of our common stock and evaluating our alternatives, if appropriate, to resolve the deficiency and regain compliance with this rule."
• "There can be no assurance that we will be able to regain compliance with the Minimum Bid Price Requirement, even if we maintain compliance with the other listing requirements."
• "There can be no assurance that we will be able to regain compliance with the Minimum Stockholders Equity Requirement, even if we maintain compliance with the other listing requirements."
• "We shifted our business strategies to focus more on development and expansion of our on-premise software revenue and SaaS revenue in the second quarter 2025, resulting in less resources and efforts were put on software development and other services."
• "Sigmaways cut down its subcontracting cost in the current quarter by ending cooperation with certain costly vendors for cost saving purpose."
• "We also improved our operational efficiency in managing of IPO consulting projects, leading to costs decreased."
• "We fully impaired intangible asset arose from acquisition of Sigmaways at the end of last fiscal year, resulting in no amortization expenses were recorded in current quarter."
• "We incurred broker fees in connection with termination of the IPO consulting services in the second quarter 2024, while no such expenses incurred in the current quarter."
• "Employee restructuring in late 2024 by transferring certain administrative and management department employees to sales department to promote selling activities for software business in Japan."
• "Development of a new product, Global CMS, started in late 2024."

Industry Context

HeartCore Enterprises operates in the competitive software development and digital transformation sectors, alongside its niche GO IPO consulting business for Japanese companies. The shift in strategy towards on-premise software and SaaS, while reducing customized development, indicates a response to market dynamics and competition, particularly in the U.S. software market. The company's efforts to expand its traditional SaaS business in Japan align with global trends of increasing cloud-based software adoption. The GO IPO consulting business, while experiencing a temporary slowdown, remains a unique offering leveraging the company's expertise in both Japanese and U.S. capital markets.

Comparison to Industry Standards

• The company's gross profit margin improvement to 46.7% in Q2 2025 is a positive sign, but still below the typical 70-80% gross margins seen in leading SaaS companies like Salesforce or Adobe, indicating a mix of software and service-based revenues.
• The decline in customized software development revenue due to "intense competition in the U.S. software market" suggests the company's services in this area may be less competitive compared to larger, more established IT consulting firms or specialized development houses.
• The Nasdaq compliance issues (bid price and stockholders' equity) are critical and indicate a struggle to meet the financial health benchmarks expected of publicly traded companies, unlike well-capitalized industry peers.
• The strategic shift to focus on on-premise software and SaaS, and away from customized development, aligns with a broader industry trend where companies prioritize scalable product offerings over bespoke services to improve margins and recurring revenue.

Corporate Governance

Legal Proceedings

• No legal proceedings currently pending against the company that are believed to have a material effect on its business, financial position, or results of operations.

Related Party Transactions

• Due to Sumitaka Yamamoto (CEO) of $590 as of June 30, 2025.
• Due to Luvina Software Joint Stock Company (non-controlling shareholder of HeartCore Luvina) of nil as of June 30, 2025.
• Accounts payable and accrued expenses of $22,924 to Luvina Software as of June 30, 2025, for software development and other support services.
• Loan receivable of $158,378 from HeartCore Technology Inc. (controlled by CEO) as of June 30, 2025.
• Short-term debt of $75,000 to Prakash Sadasivam (CEO of Sigmaways and CSO of the Company) as of June 30, 2025.
• Certain long-term debts are guaranteed by Sumitaka Yamamoto (CEO) and Prakash Sadasivam (CSO).

Stakeholder Impact

• Shareholders: Potential dilution from new share issuances (Equity Purchase Agreement, Series A Preferred Stock conversion), potential benefit from capital raise and improved Q2 profitability, but significant risk from Nasdaq delisting if compliance is not met. Reverse stock split could impact share price.
• Employees: Employee restructuring in late 2024 transferred administrative/management staff to sales, indicating a shift in internal resource allocation. Development of new products like Global CMS could create new opportunities.
• Customers: Focus shift to on-premise software and SaaS could mean improved product offerings in those areas, but less emphasis on customized software development might impact clients seeking bespoke solutions. New consulting agreements indicate continued support for IPO-bound companies.
• Creditors: Capital raises and potential sale of HeartCore Japan could improve the company's ability to meet its debt obligations, but ongoing losses and Nasdaq non-compliance pose risks.

Next Steps

• Regain compliance with Nasdaq's $1.00 minimum bid price requirement by November 3, 2025, potentially through a reverse stock split.
• Regain compliance with Nasdaq's $2,500,000 minimum stockholders' equity requirement by September 30, 2025, by completing transactions from the Equity Purchase Agreement and Securities Purchase Agreement.
• File an initial registration statement covering the resale of shares acquired by Crom Structured Opportunities Fund I, LP within 30 calendar days from June 30, 2025, and have it declared effective by the SEC within 90 days.
• Continue development of the new Global CMS product.
• Evaluate the impact of the One Big Beautiful Bill Act (OBBBA) on financial statements.
• Proceed with the non-binding letter of intent to sell 100% of HeartCore Japan for approximately $12 million.

Key Dates

Recommendation

While HeartCore Enterprises demonstrated a significant turnaround to net income in Q2 2025 and improved gross margins, driven by strategic shifts and cost controls, the overall six-month revenue decline and critical Nasdaq compliance issues (minimum bid price and stockholders' equity) present substantial risks. The recent capital raises provide necessary liquidity and are crucial for Nasdaq compliance, but the company's long-standing accumulated deficit and increased operational cash burn remain concerns. The potential sale of HeartCore Japan could be a transformative event, but its impact is uncertain. Given the mixed financial performance, the ongoing regulatory challenges, and the pending strategic divestiture, a 'hold' recommendation is appropriate. Investors should monitor the company's progress on Nasdaq compliance and the HeartCore Japan sale, as these will be key determinants of future value.

Keywords

Software Development, Customer Experience Management, Digital Transformation, Robotics Process Automation, Process Mining, Task Mining, IPO Consulting, Nasdaq Listing, SEC Filing, Quarterly Report, Financial Results, Capital Raise, Preferred Stock, Reverse Stock Split, Nasdaq Compliance, Japan Business, US GAAP, Corporate Governance, Risk Factors